Objective: Antiphospholipid antibody syndrome (APS) is an autoimmune disease characterized by the presence of β2-glycoprotein I (β2-GPI)-targeting antiphospholipid antibodies (aPLs) and vascular thrombosis or obstetrical complications. The gene discussed is APOH; the disease is autoimmune polyendocrinopathy.